Though GSK has put considerable effort into developing ... advocacy organizations and healthcare providers around the globe ...

The global sales of HBsAg testing are projected to reach USD 1,436.5 million in 2024, with expectations of growth leading to ...

Reflecting the relative health of the spatial biology field ... including sales of products or services, as well as revenue from collaborations and R&D activity. Private companies are ranked ...

Goeminne received support from AstraZeneca, Chiesi, GSK, Insmed, and Merck Sharp & Dohme ... 42 Overall, this symposium highlighted how both patients and their primary healthcare providers need to be ...

Introduction National Health ... categories of providers: hospital providers (35.4%, UI 30.3% to 38.9%), providers of ambulatory care (25.5%, UI 21.1% to 28.8%) and retailers of medical goods (14.4%, ...

Healthcare providers typically diagnose a cold by discussing symptoms and doing a physical exam. There is no test for the common cold, but the healthcare provider may run tests to rule out other ...

Despite significant medical advancements in the oncology space, 30% of patients in the GSK/Harris Poll survey said they never ...

Q3 2024 Earnings Call Transcript October 30, 2024 GSK plc beats earnings expectations. Reported EPS is $1.29, expectations were $1.23. Operator: Hello, everyone. Welcome to today’s call and webcast.